Cargando…

Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line

Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblas...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Sachiko, Matsumoto, Hiroatsu, Sonoda, Yoshiko, Ando, Kumi, Aizu-Yokota, Eriko, Sato, Toshitsugu, Kasahara, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106177/
https://www.ncbi.nlm.nih.gov/pubmed/15454116
http://dx.doi.org/10.1016/j.intimp.2004.07.023
_version_ 1783512562758844416
author Matsui, Sachiko
Matsumoto, Hiroatsu
Sonoda, Yoshiko
Ando, Kumi
Aizu-Yokota, Eriko
Sato, Toshitsugu
Kasahara, Tadashi
author_facet Matsui, Sachiko
Matsumoto, Hiroatsu
Sonoda, Yoshiko
Ando, Kumi
Aizu-Yokota, Eriko
Sato, Toshitsugu
Kasahara, Tadashi
author_sort Matsui, Sachiko
collection PubMed
description Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblasts are known as a potent producer of inflammatory chemokines, IL-8 and eotaxin 1, by which neutrophils and eosinophils are strongly attracted during inflammation. Therefore, we studied the effects of GL on the production of these chemokines using a human fetal lung fibroblast cell line, HFL-1, stimulated with TNF-α and IL-4. Moreover, we examined the structure–activity relationships of GL to explore more beneficial compounds. 18α,β-GL inhibited IL-8 dose-dependently and inhibited eotaxin 1 slightly. 18α,β-Glycyrrhetic acid (GA) did not inhibit IL-8 but inhibited eotaxin 1. The effect of 18α,β-glycyrrhetic acid monoglucuronide (MGA) resembled that of 18α,β-GL but was weaker. Both 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-11-deoxo-olean-12-en-30-oic acid (11-deoxo-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13,(18)-dien-30-oic acid (hetero-GL) exhibited inhibitory activity with significant cytotoxicity. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-oic acid (homo-GL) did not have cytotoxicity but its activity was mild like that of 18α,β-GL. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13(18)-dien-30-ol (hetero-30-OH-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-ol (homo-30-OH-GL) showed potent inhibitory effects, at concentrations lower than 18α,β-GL with no significant cytotoxicity. These results suggest that GL-related compounds are effective in reducing chemokine production and that GL-modified compounds including hetero-30-OH-GL and homo-30-OH-GL appear most beneficial in view of their inhibitory capacity with less cytotoxicity.
format Online
Article
Text
id pubmed-7106177
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71061772020-03-31 Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line Matsui, Sachiko Matsumoto, Hiroatsu Sonoda, Yoshiko Ando, Kumi Aizu-Yokota, Eriko Sato, Toshitsugu Kasahara, Tadashi Int Immunopharmacol Article Glycyrrhizin (GL) is known to have various immunomodulating activities and has long been used clinically as an anti-allergic and anti-hepatitis agent. While the potency of GL against lung inflammatory diseases has been expected, the effect of GL on the lung has been poorly understood. Lung fibroblasts are known as a potent producer of inflammatory chemokines, IL-8 and eotaxin 1, by which neutrophils and eosinophils are strongly attracted during inflammation. Therefore, we studied the effects of GL on the production of these chemokines using a human fetal lung fibroblast cell line, HFL-1, stimulated with TNF-α and IL-4. Moreover, we examined the structure–activity relationships of GL to explore more beneficial compounds. 18α,β-GL inhibited IL-8 dose-dependently and inhibited eotaxin 1 slightly. 18α,β-Glycyrrhetic acid (GA) did not inhibit IL-8 but inhibited eotaxin 1. The effect of 18α,β-glycyrrhetic acid monoglucuronide (MGA) resembled that of 18α,β-GL but was weaker. Both 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-11-deoxo-olean-12-en-30-oic acid (11-deoxo-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13,(18)-dien-30-oic acid (hetero-GL) exhibited inhibitory activity with significant cytotoxicity. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-oic acid (homo-GL) did not have cytotoxicity but its activity was mild like that of 18α,β-GL. 3β-[(2-O-β-d-Glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-olean-11,13(18)-dien-30-ol (hetero-30-OH-GL) and 3β-[(2-O-β-d-glucopyranuronosyl-β-d-glucopyranuronosyl)oxy]-18β-olean-9,12-dien-30-ol (homo-30-OH-GL) showed potent inhibitory effects, at concentrations lower than 18α,β-GL with no significant cytotoxicity. These results suggest that GL-related compounds are effective in reducing chemokine production and that GL-modified compounds including hetero-30-OH-GL and homo-30-OH-GL appear most beneficial in view of their inhibitory capacity with less cytotoxicity. Elsevier B.V. 2004 2004-08-23 /pmc/articles/PMC7106177/ /pubmed/15454116 http://dx.doi.org/10.1016/j.intimp.2004.07.023 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Matsui, Sachiko
Matsumoto, Hiroatsu
Sonoda, Yoshiko
Ando, Kumi
Aizu-Yokota, Eriko
Sato, Toshitsugu
Kasahara, Tadashi
Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title_full Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title_fullStr Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title_full_unstemmed Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title_short Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
title_sort glycyrrhizin and related compounds down-regulate production of inflammatory chemokines il-8 and eotaxin 1 in a human lung fibroblast cell line
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106177/
https://www.ncbi.nlm.nih.gov/pubmed/15454116
http://dx.doi.org/10.1016/j.intimp.2004.07.023
work_keys_str_mv AT matsuisachiko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT matsumotohiroatsu glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT sonodayoshiko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT andokumi glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT aizuyokotaeriko glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT satotoshitsugu glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline
AT kasaharatadashi glycyrrhizinandrelatedcompoundsdownregulateproductionofinflammatorychemokinesil8andeotaxin1inahumanlungfibroblastcellline